Screener
Eligibility screening
Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
29 US sites in AL, AR, AZ, CA +9
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.